Evaluation of Bone Metabolism Biomarkers in Periodontal Diseases
Evaluation Of Biomarkers Associated With Bone Metabolism İn Patients With Different Periodontal Status
1 other identifier
interventional
60
1 country
1
Brief Summary
This study evaluates the levels of biomarkers associated with bone metabolism in patients with different periodontal conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2021
CompletedFirst Submitted
Initial submission to the registry
January 9, 2023
CompletedFirst Posted
Study publicly available on registry
January 27, 2023
CompletedJanuary 27, 2023
January 1, 2023
6 months
January 9, 2023
January 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of bone metabolism biomarkers in different periodontal conditions
The levels of bone metabolism markers in the saliva of individuals with different periodontal status were compared and the relationship of these markers with periodontal status was examined.
baseline
Secondary Outcomes (3)
Probing pocket depth
baseline
Gingival index
baseline
Plaque index
baseline
Study Arms (3)
periodontitis
EXPERIMENTALgingivitis
EXPERIMENTALperiodontal healthy
EXPERIMENTALInterventions
ELISA(enzyme-linked immunosorbent assay)
Eligibility Criteria
You may qualify if:
- years old.
- not having any systemic disease that may affect periodontal status
- not smoking and alcohol use
- volunteer to participate in the study
You may not qualify if:
- periapical pathologies;
- resulting from orthodontics and occlusion extreme forces, including mechanical forces;
- chronic high-dose steroid therapy;
- radiation or immunosuppressive therapy;
- pregnancy;
- breastfeeding;
- allergy or sensitivity to any medication.
- Periodontal therapy or drug therapy for at least 6 months of study participants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Necmettin Erbakan University
Konya, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- master in science
Study Record Dates
First Submitted
January 9, 2023
First Posted
January 27, 2023
Study Start
November 5, 2020
Primary Completion
May 5, 2021
Study Completion
November 5, 2021
Last Updated
January 27, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share